Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 7

1.

Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation.

Ansieau S, Scheffrahn I, Mosialos G, Brand H, Duyster J, Kaye K, Harada J, Dougall B, Hübinger G, Kieff E, Herrmann F, Leutz A, Gruss HJ.

Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14053-8. Retraction in: Kieff E. Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12732.

2.

Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling.

Wajant H, Scheurich P.

Int J Biochem Cell Biol. 2001 Jan;33(1):19-32. Review.

PMID:
11167129
3.
4.

The nerve growth factor/tumor necrosis factor receptor family.

Lotz M, Setareh M, von Kempis J, Schwarz H.

J Leukoc Biol. 1996 Jul;60(1):1-7. Review.

5.

The seventh ring: exploring TRAF7 functions.

Zotti T, Vito P, Stilo R.

J Cell Physiol. 2012 Mar;227(3):1280-4. doi: 10.1002/jcp.24011. Review.

PMID:
22105767
6.

Roles of TRAF molecules in B lymphocyte function.

Xie P, Kraus ZJ, Stunz LL, Bishop GA.

Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):199-207. doi: 10.1016/j.cytogfr.2008.04.002. Epub 2008 May 21. Review.

7.

CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy.

Falini B, Pileri S, Pizzolo G, Dürkop H, Flenghi L, Stirpe F, Martelli MF, Stein H.

Blood. 1995 Jan 1;85(1):1-14. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk